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The aim of the study was to find out the carbapenem resistance rate and
prevalence of different carbapenemase genes in Klebsiella pneumoniae and
Escherichia coli from a North Indian corporate hospital that receives both Indian
and international patients. A total of 528 clinical isolates of E. coli and K. pneumoniae
were included in the study. All isolates that were found resistant to carbapenems by
MIC testing (Vitek II Compact®) were screened for NDM, OXA-48, VIM, and KPC
genes by PCR. Sequencing of NDM gene and transmissibility by conjugation assay
were checked on 22 randomly selected NDM-positive isolates. One hundred and
fifty-six isolates (29.54%) were carbapenem-resistant. The rate of carbapenem
resistance was significantly higher in K. pneumoniae as compared to E. coli
(53.9% vs. 15.6%; p< 0.05). The NDM gene was found in 34.6% (54/156),
OXA-48 in 31.4% (49/156), co-expression of NDM+OXA-48 in 15.3% (24/156)
of the carbapenem-resistant isolates. VIM and KPC were absent in all isolates. NDM
gene was significantly more prevalent in E. coli than K. pneumoniae (p< 0.05).All the
tested isolates formed transconjugants and NDM-5 was the most common variant in
both species (15/22). The presence of plasmid-based NDM calls for stricter surveil-
lance measures in our hospital settings.
Keywords: carbapenemase, NDM, OXA-48, Escherichia coli, Klebsiella
pneumoniae
*Corresponding author; E-mail: namita@artemishospitals.com
Acta Microbiologica et Immunologica Hungarica 66 (3), pp. 367–376 (2019)
DOI: 10.1556/030.66.2019.020
1217-8950/$20.00 © 2019 Akadémiai Kiado´, Budapest
Introduction
Carbapenems are the antibiotics of choice for infections caused by
cephalosporin-resistant bacteria. [1, 2]. However, resistance to carbapenems has
currently become predominant in almost all groups of pathogenic bacteria
including Enterobacteriaceae [2]. Carbapenem-resistant (CR) Enterobacteriaceae
poses a serious threat to antibiotic therapy as it results in high rate of morbidity and
mortality [3, 4]. Carbapenemases are the major mechanisms of resistance, and
carbapenemase harboring isolates have been reported from across the globe with
varying rates of prevalence. Globally, Klebsiella pneumoniae carbapenemase
(KPC) is the most common carbapenemase, while in the Indian subcontinent,
New Delhi metallo-β-lactamase (NDM), which supposedly originated in India in
2008, is the most commonly reported carbapenemase [2, 5]. Various variants of
NDM differing from each other in one or few nucleotides have emerged over the
years [6, 7]. Besides NDM, oxacillinase-48 (OXA-48)-like enzymes have also
been reported from India [8]. In India, NDM has spread to community and has
been reported from public tap water and sewage isolates [9].
Escherichia coli and Klebsiella pneumoniae are the most common Gram-
negative pathogens in clinical microbiology laboratories, and the resistance rate to
carbapenems in these organisms is high in India [10]. The rise in antimicrobial
resistance poses a serious challenge in centers where international patients come
for treatment. This study was undertaken in a corporate hospital in North India that
caters to both Indian and international patients with the aim to find out the
prevalence of important carbapenemases in E. coli and K. pneumoniae.
Materials and Methods
Study design, bacterial isolates, and patient profile
The study was carried out at a tertiary care referral hospital in Gurugram,
North India. The study design was approved by the institutional ethics com-
mittee. A total of 528 non-duplicated, consecutive E. coli and K. pneumoniae
isolates were recovered from various clinical samples, such as urine, sputum,
blood, pus, stool, tracheal aspirate, and body fluids. The samples were received
in the clinical microbiology department from both inpatient [including intensive
care unit (ICU)] and outpatient departments between November 2017 and
February 2018. The details pertaining to patient’s background, such as age,
gender, nationality, locations, and mortality, were retrieved from the Hospital
Information System.
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Antimicrobial susceptibility
Standard bacteriological techniques were used for the isolation of the
organisms [11]. Identification of isolates and antibiotic susceptibility testing was
performed on automated Vitek-2 compact system (Biomerieux, France). Isolates
confirmed as E. coli and K. pneumoniae and showing resistance to carbapenems
based on minimum inhibitory concentration (MIC) values (as determined by Vitek
system and interpreted according to CLSI guidelines) [12] were further subjected
to polymerase chain reaction (PCR) for determining the presence of various
carbapenemase genes.
Detection of carbapenemases by PCR and NDM sequencing
Total DNA was extracted by the boiling lysis method as described earlier
[13]. Detection of carbapenemase genes, such as NDM, OXA-48, Verona
integron–encoded metallo-β-lactamase (VIM), and KPC, was carried out using
PCR. The positive controls for the carbapenemase genes were obtained from the
Microbiology Lab of Christian Medical College, Vellore, India. The PCR
reaction was carried out in a 20-μl reaction consisting of 10 μl of commercial
2× taq polymerase master mix (Qiagen cat# 201443), 0.5 μM of forward and
reverse primers, and 2 μl of DNA template. The PCR included initial denatur-
ation of 95 °C for 5 min followed by 35 cycles of denaturation at 95 °C at 1 min,
annealing at 55 °C for 1 min (for NDM annealing at 60 °C), extension at 72 °C
for 1 min, and a single cycle of final extension at 72 °C for 7 min. The amplified
products were run on 1.5% agarose gel and visualized under UV light using a
Gel Doc (Molecular Imager, Biorad, Hercules, CA, USA). The primer sequence
for NDM, VIM, and KPC was taken from existing literature [14, 15]. Primer
sequence for screening of OXA-48 (forward: GTTCATCCTTAACCACGCCC;
reverse: CGGTAGCAAAGGAATGGCAA) and NDM sequencing (forward:
ATTAGCCGCTGCATTGAT; reverse: GGGCCGTATGAGTGATTG) was
designed during this study using Primer3 software (https://www.ncbi.nlm.nih.
gov/tools/primer-blast/).
The identification of NDM variants was performed as follows: a portion of
NDM gene spanning 743 bp was amplified by PCR and amplicons were purified
using a PCR purification kit (Qiagen cat# 28004) and were sequenced (Applied
Biosystems, ABI3730 XL, Foster City, CA, USA). The sequenced data were
compared with sequences of various NDM determinants obtained from NCBI
using BLAST software (http://www.ncbi.nlm.nhi.gov/blast/).
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Conjugation
Conjugation assay was performed by plate mating. Overnight cultures of
donor strain and recipient strain of E. coli J53 (AzideR) were diluted 1:10 and
1:100, respectively, and allowed to grow at 37 °C for an hour. Conjugation by
plate mating was performed by mixing these cultures in 1:1 ratio and streaking on
Mueller–Hinton agar (MHA) plates followed by incubation at 37 °C for 4 h. The
transconjugants were selected by plating on MHA plates containing 2 μg/ml
meropenem and 200 mg/L sodium azide. All transconjugants were tested for the
presence of NDM by PCR.
Statistical analysis
The data are represented as absolute numbers and percentages. Nominal
categorical data between the groups were compared by χ2 test or Fisher’s exact test
as appropriate. All major data analyses were performed using Microsoft Excel. For
all statistical tests, a p value less than 0.05 was taken to indicate a significant
difference.
Results
A total of 528 isolates of K. pneumoniae and E. coli from 488 patients were
included in this study. About 51.8% (n= 253) of the patients were males and the
median age of the patients was 55 years. The rate of carbapenem resistance was
significantly higher in males as compared to females (p< 0.001). There was no
significant difference in the carbapenem resistance rate between Indian and
international patients (p> 0.05). Carbapenem resistance rate was significantly
higher in the inpatients than outpatients (p< 0.0001). In addition, we observed
gender- and location-wise differences in the distribution of the two organisms
under the study. CR K. pneumoniaewas significantly higher in males as compared
to females (p< 0.05), but the same was not true in case of CR E. coli. The rate of
carbapenem resistance according to gender, nationality, and location in all patients
and in the two organisms is detailed in Table I.
Of the total 528 isolates, 156 (29.54%) showed resistance to carbapenems.
E. coli comprised 64.01% (338/528) of the total isolates; however, the rate of
carbapenem resistance in E. coli was significantly less than K. pneumoniae
(15.6% vs. 53.9%; p< 0.0001). K. pneumoniae dominated most sample
types except for stool where E. coli was predominant. The majority (43.6%) of
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CR K. pneumoniae isolates was from ICU, whereas the major percentage of CR E.
coli (47.1%) was from wards. The distribution of CR E. coli and K. pneumoniae in
various sample types and locations is depicted Figure 1.
The prevalence of NDM and OXA-48 in the overall isolates was 34.6% and
31.4%, respectively. In 15.3% isolates, co-expression of NDM and OXA-48 was
observed, while VIM and KPC were absent in all isolates. In 18.5% isolates,
none of the tested carbapenemase genes were detected. The prevalence of
Table I. Demographics of carbapenem-resistant patients





K. pneumoniae E. coli
Gender Males (253) 88 61 27
Females (235) 48 27 21
Nationality Indian (426) 118 76 42
International (62) 18 12 6
Location Outpatients (217) 33 20 13
Wards (152) 53 32 21
ICU (119) 50 37 13
Note: ICU: intensive care unit.
Figure 1. Distribution of K. pneumoniae and E. coli in different sample types and location
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carbapenemase genes NDM and OXA-48 in the two species and in various sample
types was not uniform. NDM gene alone or in combination with OXA-48 was
present in 77% of CR E. coli as compared to 35.9% of CR K. pneumoniae. The
distribution of carbapenemases NDM and OXA-48 in the two organisms and
various sample types is shown in Figure 2.
Twenty-two NDM-positive isolates were randomly selected for sequencing.
NDM-5 was the predominant variant in both the species. Out of the 13 NDM-
positive isolates of K. pneumoniae that were sequenced for the NDM gene, 9 were
NDM-5 and 4 were NDM-1. In E. coli, 6 out of 9 were NDM-5 and one each was
NDM-1, NDM-6, and NDM-7. All the derived sequences were submitted to
GenBank and have been assigned the following accession numbers (MH683602–
MH683610 and MH-744357–MH744369). Conjugation assay was carried out to
check the location (plasmid/chromosomal) on all the isolates that were sequenced.
All the isolates formed transconjugants in conjugation assay that were positive for
NDM in PCR, indicating the presence of NDM gene on plasmids.
In this study, 62 isolates came from international patients hailing from 16
different countries, mainly from West Asian, Eastern European, and African
nations. Twenty-three isolates, those belonging to countries of Iraq, Afghanistan,
Uganda, Kenya, Uzbekistan, Sudan, and UK, exhibited carbapenem resistance.
Maximum numbers of isolates (36) were from Iraq, of which 13 showed
carbapenem resistance. Of the 23 CR isolates, 6 expressed the NDM gene of
which 3 were from Iraqi nationals, and one each was from patients belonging to
Figure 2. Distribution of carbapenemase in E. coli and K. pneumoniae and various sample types
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Uganda, Uzbekistan, and Sudan. OXA-48 expression was seen in seven isolates in
patients belonging to Iraq (5), Afghanistan (1), and UK (1). Three isolates from
Iraqi patients and two from Kenyan patients co-expressed the NDM and OXA-48
genes. In the remaining five isolates, none of the tested carbapenemases were
detected. The isoforms of NDM observed in Iraqi patients were NDM-5, NDM-1,
and NDM-6. NDM-5 was also found in one patient each from Uganda and Sudan.
As compared to OXA-48, NDM-carrying E. coli isolates were more likely to
have a highMIC range for meropenem taking an arbitrary cut-off of 8 μg/ml, while
in K. pneumoniae a similar trend was seen for imipenem (p< 0.05). Isolates
co-expressing NDM and OXA-48 were likely to have a higher MIC range than
OXA-48 alone but the results were not statistically significant. There was no
difference in the MIC range of the two carbapenems in the various variants of NDM.
Mortality rates were significantly higher in patients harboring CR isolates
than the carbapenem-sensitive ones (21% vs. 7%; p< 0.05). Within the CR group,
the presence of carbapenemase genes did not have any significant effect on
mortality rates (p> 0.05).
Discussion
Antibiotic resistance is a public health menace in India and the rate of
carbapenem resistance is also showing an alarmingly increasing trend [16].
Although reports on CR bacteria and prevalence of carbapenemase genes from
North India are frequent, we conducted this study in our hospital settings because
it is a multispecialty set up and around 15% of our patients are from abroad. The
study also will help us in modifying and upgrading existing antibiotic stewardship
policies of the institution.
The rate of carbapenem resistance was significantly higher in males than in
females and this was particularly true for CR K. pneumoniae. This could be due to
the fact that majority of the CR K. pneumoniae was isolated from ICU, where 67%
of the patients were males. Second, we did not find any remarkable difference in
rate of carbapenem resistance in Indian and international patients. This was not
surprising as the majority (56%) of the foreign patients in the study was from Iraq
where the rate of carbapenem resistance is high and the presence of NDM and
OXA-48 genes in CR isolates has been previously reported [17, 18]. Isolates from
foreign patients other than Iraq were represented by less than 10 samples.
Of the four carbapenemases screened in the study, NDM was the most
common followed by OXA-48, which is similar to the previous findings from
North India in the recent past [8]. However, distribution of the two genes in the
two species under the study and in various sample types was not uniform. The rate
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of carbapenem resistance is higher in K. pneumoniae than in E. coli, which is in
accordance with earlier reports [19]. The prevalence of NDM in E. coli was much
higher than in K. pneumoniae. E. coli was abundant in stool and urine samples
where the origin of infection is mostly from the gut microflora, suggesting that
NDM-harboring E. coli might be present in the gut microflora in the community.
On the other hand, blood and sputum samples were mainly reported from ICU and
they showed a predominance of OXA-48-containing K. pneumoniae.
Various variants of NDM have been reported from North India and Delhi
previously [20, 21], but our data assume significance as it has been carried out on
both Indian and international patients. This study identified NDM-5 as the most
common variant in our hospital settings followed by NDM-1, which is probably
the first in its kind of report. NDM-5 was isolated from samples of both Indian and
international patients. Due to limitations, we are unable to ascertain the clonal
relationship between these isolates. Moreover, the result of conjugation assay
indicates plasmid-based location in all the isolates that were sequenced. This calls
for stricter surveillance and infection control measures as plasmid-based genes can
be transferred between species and spread rapidly.
OXA-48 is a weak carbapenemase that has the chance to be missed in
phenotypic tests. However, in combination with carbapenem resistance mechan-
isms, such as efflux pump, porins, or other carbapenamse genes, OXA-48
increases the potency of carbapenem resistance manifolds [2]. Our results also
support the above observations. In this study, the MIC values for imipenem were
significantly high in K. pneumoniae isolates harboring NDM than those harboring
OXA-48 and the similar was true for meropenem in E. coli isolates. Similarly,
OXA-48 in combination with NDM had higher range of MIC for imipenem in K.
pneumoniae, although the values were not statistically significant.
In this study, 27 isolates of K. pneumoniae and two isolates of E. coli were
negative for all the tested carbapenemases. This indicates that these isolates of K.
pneumoniae have mechanisms other than carbapenemase-like efflux pumps or
porins to resist the carbapenems, which need further investigation. This baseline
data generated from this study in a multispeciality hospital is important in view of
the growing antibiotic resistance and flourishing medical tourism.
Abbreviations
NDM : New Delhi metallo-β-lactamase
OXA-48 : oxacillinase-48
VIM : Verona integron-encoded metallo-β-lactamase
KPC : Klebsiella pneumoniae carbapenemase
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PCR : polymerase chain reaction
MIC : minimum inhibitory concentration
CR : carbapenem-resistant
ND : none of the tested carbapenemase detected
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